Alexander Schulz PhD
Person

Affiliations

Department of Dermatology
- Academic Staff
- alexander.schulz1@tu-dresden.de

Identification Numbers

ORCID	0000-0001-7499-5125
Scopus author ID	55730167300

Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases

Westphal, D., Meinhardt, M., Grützmann, K., Schöne, L., Steininger, J., Neuhaus, L. T., Wiegel, M., & 16 othersSchrimpf, D., Aust, D. E., Schröck, E., Baretton, G. B., Beissert, S., Juratli, T. A., Schackert, G. G., Gravemeyer, J., Becker, J. C., von Deimling, A., Koelsche, C., Klink, B., Meier, F., Schulz, A., Muders, M. H. & Seifert, M., 27 Jan 2023, (E-pub ahead of print) In: Journal of Investigative Dermatology. 30 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Head-to-Head Comparison of BRAF/MEK Inhibitor Combinations Proposes Superiority of Encorafenib Plus Trametinib in Melanoma

Schulz, A., Raetz, J., Karitzky, P. C., Dinter, L., Tietze, J. K., Kolbe, I., Käubler, T., & 4 othersRenner, B., Beissert, S., Meier, F. & Westphal, D., Oct 2022, In: Cancers. 14, 19, 4930.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (7)

Research Portal of the TU Dresden

Alexander Schulz PhD
Person

Affiliations

Identification Numbers

Related content

Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases

Head-to-Head Comparison of BRAF/MEK Inhibitor Combinations Proposes Superiority of Encorafenib Plus Trametinib in Melanoma

Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies

Systemic therapy of metastatic melanoma: On the road to cure

Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer